PTAB denies Celltrion’s patent challenge against Genentech

07-03-2017

PTAB denies Celltrion’s patent challenge against Genentech

Duncan_Andison / iStockphoto.com

The Patent Trial and Appeal Board (PTAB) has rejected Celltrion’s challenge against a Genentech patent centring on a method of treating rheumatoid arthritis, stating that the challenged patent did not show any reasonable likelihood of being invalid.


PTAB, USPTO, Celltrion, patent, IPR, Genentech

More on this story

PTAB grants rehearing of Genentech patent IPR
31-10-2017

LSIPR